Evidence map›Paper›PMID 40480755›Full record

ArticleJACC. Case reports2025

Left Ventricular Assist Device Implantation in the Presence of Substernal Extravascular Implantable Cardioverter-Defibrillator.

Roland Papp, Levente Molnár, Éva Straub, Endre Németh, Endre Zima, Ádám Levente Jermendy, Balázs Sax, Csilla Czimbalmos, István Hartyánszky, Béla Merkely

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Roland PappHeart and Vascular Centre, Semmelweis University, Budapest, Hungary. Electronic address: roland.pappdr@gmail.com.
Levente MolnárHeart and Vascular Centre, Semmelweis University, Budapest, Hungary.
Éva StraubHeart and Vascular Centre, Semmelweis University, Budapest, Hungary.
Endre NémethHeart and Vascular Centre, Semmelweis University, Budapest, Hungary.
Endre ZimaHeart and Vascular Centre, Semmelweis University, Budapest, Hungary.
Ádám Levente JermendyHeart and Vascular Centre, Semmelweis University, Budapest, Hungary.
Balázs SaxHeart and Vascular Centre, Semmelweis University, Budapest, Hungary.
Csilla CzimbalmosHeart and Vascular Centre, Semmelweis University, Budapest, Hungary.
István HartyánszkyHeart and Vascular Centre, Semmelweis University, Budapest, Hungary.
Béla MerkelyHeart and Vascular Centre, Semmelweis University, Budapest, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extravascular implantable cardioverter-defibrillator is a recently developed substernal system to prevent sudden cardiac death. Extravascular devices, such as subcutaneous and substernal implantable cardioverter-defibrillators, were designed to avoid the possible complications of conventional transvenous leads. However, their combination with a left ventricular assist device (LVAD) is often challenging. Electromagnetic interference generated by the LVAD may affect previously implanted cardioverter-defibrillators, particularly subcutaneous extravascular devices. To our knowledge, this is the first reported experience of the concomitant use of an extravascular implantable cardioverter-defibrillator with a durable LVAD.

Indexed as

cardiac assist devicessubsternal extravascular implantable cardioverter-defibrillatorsystolic heart failureventricular fibrillation

Identifiers

PMID40480755
PMCPMC12235159

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.